Influence of COVID-19 infection on the early clinical efficacy of patients undergoing single valve replacement surgery: A retrospective cohort study
- VernacularTitle:新型冠状病毒感染对单瓣膜置换术患者早期临床疗效影响的回顾性队列研究
- Author:
Liu XU
1
,
2
;
Yongfeng HUO
1
,
2
;
Lijun TIAN
1
,
2
;
Yun ZHU
1
,
2
;
Juan XIAO
1
,
2
;
Ruiyan MA
1
,
2
Author Information
1. Department of Cardiovascular Surgery, The Second Affiliated Hospital of Chinese People'
2. s Liberation Army Medical University, Chongqing, 400037, P. R. China
- Publication Type:Journal Article
- Keywords:
Cardiopulmonary bypass;
valve replacement;
COVID-19
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(05):634-638
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the impact of COVID-19 infection on the early clinical outcomes of patients undergoing valve replacement. Methods Perioperative data of patients who underwent single valve replacement at the Second Affiliated Hospital of Chinese People's Liberation Army Medical University from January to February 2023 were consecutively collected. Based on COVID-19 infection status, patients were divided into a COVID-19 group and a non-COVID-19 group. The perioperative data were compared between the two groups. Results A total of 136 patients were included, comprising 53 males and 83 females, with a mean age of (53.4±10.2) years. There were 32 patients receiving aortic valve replacements, 102 mitral valve replacements, and 2 tricuspid valve replacements. The COVID-19 group comprised 70 patients, and the non-COVID-19 group included 66 patients. No statistical difference was observed in the incidence of postoperative complications between the two groups [9.09% (6/66) vs. 11.43% (8/70), P=0.654]. However, the COVID-19 group had longer postoperative mechanical ventilation duration [1 201.00 (1 003.75, 1 347.75) min vs. 913.50 (465.50, 1 251.00) min, P=0.001] and ICU stay [3 (2, 3) days vs. 2 (2, 3) days, P<0.001] compared to the non-COVID-19 group. Additionally, troponin I [4.76 (2.55, 7.93) ng/mL vs. 2.66 (1.19, 5.65) ng/mL, P=0.001] and brain natriuretic peptide [608.50 (249.75, 1 150.00) pg/mL vs. 192.00 (100.93, 314.75) pg/mL, P<0.001] levels were significantly higher in the COVID-19 group. Conclusion For patients with single valve disease undergoing elective surgery, short-term outcomes after recovery from COVID-19 infection are favorable, with no significant increase in in-hospital mortality or postoperative complication rates.
